Traws Pharma(TRAW.US)

Last Updated 19:00:00 ET
longbridge loading

Traws Pharma, Inc. 1Q 2026: Revenue $0 EPS $(0.53) — 10-Q Summary

TradingView·
US
TRAW
+1.89%
US
LABU
+11.76%
US
FBT
+2.14%
TradingView·
US
TRAW
+1.89%
US
LABU
+11.76%
US
FBT
+2.14%

Earnings Scheduled For May 15, 2026

benzinga_article·
US
TRAW
+1.89%
US
INDP
-7.52%
US
MCB
+2.86%
benzinga_article·
US
TRAW
+1.89%
US
INDP
-7.52%
US
MCB
+2.86%

Traws Pharma | 8-K: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
TRAW
+1.89%
Earnings Watch·
US
TRAW
+1.89%

TRAW Q1'26 Earnings: EPS estimate is (0.56) USD

TradingView·
US
TRAW
+1.89%
US
VHT
+0.27%
US
PBE
+1.60%
TradingView·
US
TRAW
+1.89%
US
VHT
+0.27%
US
PBE
+1.60%

Sector Update: Healthcare Stocks Lower in Afternoon Trading

Fidelity·
US
ZTS
+1.00%
US
XHS
+0.93%
US
LABU
+11.76%
Fidelity·
US
ZTS
+1.00%
US
XHS
+0.93%
US
LABU
+11.76%

Traws Climbs 20% On Hantavirus Drug Development Push

nasdaq·
US
TRAW
+1.89%
US
VHT
+0.27%
US
FBT
+2.14%
nasdaq·
US
TRAW
+1.89%
US
VHT
+0.27%
US
FBT
+2.14%
© 2026 Longbridge｜Disclaimer